TBCRC 002: a phase II, randomized, open-label trial of...

Breast Cancer Research 2020 / 12 Vol. 22; Iss. 1

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Vaklavas, Christos, Roberts, Brian S., Varley, Katherine E., Lin, Nancy U., Liu, Minetta C., Rugo, Hope S., Puhalla, Shannon, Nanda, Rita, Storniolo, Anna Maria, Carey, Lisa A., Saleh, Mansoor N., Li,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-020-01258-x
Date:
December, 2020
File:
PDF, 1.20 MB
english, 2020
Conversion to is in progress
Conversion to is failed